BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24502199)

  • 21. Influences of genetic variation on fetal hemoglobin.
    He Y; Lin W; Luo J
    Pediatr Hematol Oncol; 2011 Nov; 28(8):708-17. PubMed ID: 22023465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
    Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
    Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Existence of HbF Enhancer Haplotypes at
    Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
    Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia.
    Qadah T; Noorwali A; Alzahrani F; Banjar A; Filimban N; Felimban R
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):705-710. PubMed ID: 33100714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Nogueira BL; Belisário AR; Faria G; Mendes F; Viana MB; Luizon MR
    J Hum Genet; 2022 Dec; 67(12):701-709. PubMed ID: 36167770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
    Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
    Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.
    Keyhani E; Jafari Vesiehsari M; Talebi Kakroodi S; Darabi E; Zamani F; Karimlou M; Kamali K; Neishabury M
    Hemoglobin; 2016 Jun; 40(3):198-201. PubMed ID: 27117569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults.
    Thein SL; Menzel S; Peng X; Best S; Jiang J; Close J; Silver N; Gerovasilli A; Ping C; Yamaguchi M; Wahlberg K; Ulug P; Spector TD; Garner C; Matsuda F; Farrall M; Lathrop M
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11346-51. PubMed ID: 17592125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease.
    Al-Allawi N; Qadir SMA; Puehringer H; Chui DHK; Farrell JJ; Oberkanins C
    Int J Lab Hematol; 2019 Feb; 41(1):87-93. PubMed ID: 30216683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.
    Banan M; Bayat H; Namdar-Aligoodarzi P; Azarkeivan A; Kamali K; Daneshmand P; Zaker-Kandjani B; Najmabadi H
    Hemoglobin; 2013; 37(5):413-22. PubMed ID: 23805990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multi-locus Approach to Characterization of Major Quantitative Trait Loci Influencing Hb F Regulation in Chinese β-thalassemia Carriers.
    Chan NC; Lau KM; Cheng KC; Chan NP; Ng MH
    Hemoglobin; 2016 Nov; 40(6):400-404. PubMed ID: 27707011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long noncoding RNA from the HBS1L-MYB intergenic region on chr6q23 regulates human fetal hemoglobin expression.
    Morrison TA; Wilcox I; Luo HY; Farrell JJ; Kurita R; Nakamura Y; Murphy GJ; Cui S; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2018 Mar; 69():1-9. PubMed ID: 29227829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.
    So CC; Song YQ; Tsang ST; Tang LF; Chan AY; Ma ES; Chan LC
    J Med Genet; 2008 Nov; 45(11):745-51. PubMed ID: 18697826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients.
    Bashir S; Mahmood S; Mohsin S; Tabassum I; Ghafoor M; Sajjad O
    J Pak Med Assoc; 2021 May; 71(5):1394-1398. PubMed ID: 34091621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique Polymorphisms at
    Akbulut-Jeradi N; Fernandez MJ; Al Khaldi R; Sukumaran J; Adekile A
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
    Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
    BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.
    Danjou F; Anni F; Perseu L; Satta S; Dessì C; Lai ME; Fortina P; Devoto M; Galanello R
    Haematologica; 2012 Jul; 97(7):989-93. PubMed ID: 22271886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
    Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
    FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
    Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
    Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.
    Cardoso GL; Diniz IG; Silva AN; Cunha DA; Silva Junior JS; Uchôa CT; Santos SE; Trindade SM; Cardoso Mdo S; Guerreiro JF
    Blood Cells Mol Dis; 2014 Dec; 53(4):176-9. PubMed ID: 25084696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.